Home > Boards > US Listed > Medical - Drugs > ANI Pharmaceuticals (ANIP)

$3.30 pre-split after buying 20 generic drugs from

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
mlkrborn Member Profile
 
Followed By 39
Posts 7,816
Boards Moderated 1
Alias Born 01/04/06
160x600 placeholder
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 11/23/2020 4:28:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 5:12:55 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 8:30:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 6:59:45 AM
ANI Pharmaceuticals Reports Third Quarter 2020 Results Business Wire - 11/5/2020 6:50:00 AM
ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial Results Business Wire - 10/29/2020 6:50:00 AM
ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 9/10/2020 7:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/10/2020 6:19:28 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/10/2020 6:18:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2020 4:19:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/7/2020 7:35:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/7/2020 7:33:46 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/7/2020 7:30:06 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/7/2020 7:27:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 4:18:07 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 8:32:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 6:55:38 AM
ANI Pharmaceuticals Reports Second Quarter 2020 Results Business Wire - 8/6/2020 6:50:00 AM
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma & Antonio “Tony” Pera to Board of Direct... Business Wire - 8/6/2020 6:45:00 AM
ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer Business Wire - 8/3/2020 6:50:00 AM
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results Business Wire - 7/30/2020 6:50:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/20/2020 6:03:45 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/9/2020 4:18:06 PM
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets PR Newswire (US) - 7/6/2020 8:30:00 AM
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules PR Newswire (US) - 6/30/2020 8:30:00 AM
mlkrborn   Tuesday, 12/31/13 04:05:00 PM
Re: None
Post # of 12250 
$3.30 pre-split after buying 20 generic drugs from TEVA. Still affordable. Question is why TEVA dumped those generics ?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences